ALFA FinderBSE filing, NSE: AARTIPHARM. Summary written from the filing by ALFA Finder's alert engine.
Aarti Pharmalabs Ltd: key numbers
- Share price
- ₹929.10
- Market cap
- ₹8,425 Cr
- Revenue (annual)
- ₹1,819 Cr
- Net profit (annual)
- ₹174.7 Cr
- P/E (TTM)
- 32.8×Sector 43.0×
- Promoter holding
- 39.66%-3.20% QoQ
- FII holding
- 8.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Pharmalabs Ltd
All →Aarti Pharmalabs Earnings Call Transcript: Key Takeaways
Aarti Pharmalabs delivered record quarterly revenue driven by strong CDMO growth, though aggressive capex is temporarily elevating debt and working capital.
- Call
- Guides 45% growth
Aarti Pharmalabs Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue INR 6,126Mn (+46.8% YoY), EBITDA INR 1,358Mn (22.2% margin), PAT INR 658Mn (+180% YoY). H1 revenue +44.7%. Xanthine capacity expansion and Atali capex drive growth.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
Aarti Pharmalabs Q2 FY27 Results: Net Profit ₹71.5 Cr, Up 248.8% YoY
Aarti Pharmalabs Ltd reported revenue from operations of ₹610.5 Cr (+45.9% YoY) and net profit of ₹71.5 Cr (+248.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹71.5 Cr · +248.8% YoY
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
Other annual general meeting announcements
All →Kirloskar Industries Annual General Meeting
Kirloskar Industries forwarded its subsidiary KFIL's postal ballot scrutinizer report. Shareholders passed resolutions appointing Ajay Shriram Patil as a director and as Joint Managing Director.
Umiya Tubes Annual General Meeting
Umiya Tubes submitted voting results and the scrutinizer report for its postal ballot ending 7 November 2026. Resolution 1, alteration of the name clause, passed as a special resolution with 100% of votes cast in favour.
Prime Focus Annual General Meeting
Prime Focus Limited's EOGM held on 7 November 2026 passed all resolutions with requisite majority. Resolutions cover cessation of control over Brahma AI Holdings and related party transactions involving its subsidiaries.
Jagsonpal Services Annual General Meeting
Jagsonpal Services shareholders approved an asset-acquisition business transfer agreement with Elanistech via postal ballot. A name-change certificate was also noted.
Vineet Laboratories Annual General Meeting
Vineet Laboratories has circulated notice of its 10th AGM, scheduled for 30 November 2026 via video conferencing. The filing attaches the FY 2025-26 annual report.
Jiwanram Sheoduttrai Industries Annual General Meeting
Jiwanram Sheoduttrai Industries received a two-month RoC extension to hold its 29th AGM for FY2025-26. The AGM must now be held by 30 November 2026.